Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study

Authors: Annie Saint-Remy, Mélanie Somja, Karen Gellner, Laurent Weekers, Catherine Bonvoisin, Jean-Marie Krzesinski

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

In kidney transplant (Kt) recipients , hypertension is a major risk for cardiovascular complications but also for graft failure. Blood pressure (BP) control is therefore mandatory. Office BP (OBP) remains frequently used for clinical decisions, however home BP (HBP) have brought a significant improvement in the BP control. Sodium is a modifiable risk factor, many studies accounted for a decrease of BP with a sodium restricted diet. Increased potassium intake has been also recommended in hypertension management. Using an agreement between office and home BP, the present study investigated the relations between the BP control in Kt recipients and their urinary excretion and dietary consumption of sodium and potassium.

Methods

The BP control defined by OBP <140/90 mmHg and HBP <135/85 mmHg was tested in 70 Kt recipients (mean age 56 ± 11.5 years; mean graft survival 7 ± 6.6 years) treated with antihypertensive medications. OBP and HBP were measured with a validated oscillometric device (Omron M6®). The 24-hour urinary sodium (Na+) and potassium (K+) excretions as well as dietary intakes were compared between controlled and uncontrolled (in office and at home) recipients. Non parametric Wilcoxon Mann–Whitney Test was used for between groups comparisons and Fisher's exact test for frequencies comparisons. Pearson correlation coefficients and paired t-test were used when sample size was >30.

Results

Using an agreement between OBP and HBP, we identified controlled (21%) and uncontrolled recipients (49%). Major confounding effects susceptible to interfere with the BP regulation did not differ between groups, the amounts of sodium excretion were similar (154 ± 93 vs 162 ± 88 mmol/24 h) but uncontrolled patients excreted less potassium (68 ± 14 vs 54 ± 20 mmol/24 h; P = 0.029) and had significantly lower potassium intakes (3279 ± 753 vs 2208 ± 720 mg/24 h; P = 0.009), associated with a higher urinary Na+/K + ratio. Systolic HBP was inversely and significantly correlated to urinary potassium (r = −0.48; P = 0.002), a positive but non significant relation was observed with urinary sodium (r = 0,30;P = 0.074).

Conclusions

Half of the treated hypertensive Kt recipients remained uncontrolled in office and at home. Restoring a well-balanced sodium/potassium ratio intakes could be a non pharmacological opportunity to improve blood pressure control.
Literature
1.
go back to reference First M: for the Transplant Therapy Outcomes Study Group. Study 1: long-term cardiovascular risk after kidney transplantation. Transplant Rev. 2003, 4: s47-CrossRef First M: for the Transplant Therapy Outcomes Study Group. Study 1: long-term cardiovascular risk after kidney transplantation. Transplant Rev. 2003, 4: s47-CrossRef
2.
go back to reference Campistol J, Romero R, Paul J, Guttiérrez-Dalmau A: Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Nephrol Dial Transplant. 2004, 19 (suppl 3): 62-66. Campistol J, Romero R, Paul J, Guttiérrez-Dalmau A: Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Nephrol Dial Transplant. 2004, 19 (suppl 3): 62-66.
3.
go back to reference Opelz G, Wujciak T, Ritz E: Association of chronic kidney graft failure with recipient blood pressure. Kidney Int. 1998, 53: 217-222. 10.1046/j.1523-1755.1998.00744.x.CrossRefPubMed Opelz G, Wujciak T, Ritz E: Association of chronic kidney graft failure with recipient blood pressure. Kidney Int. 1998, 53: 217-222. 10.1046/j.1523-1755.1998.00744.x.CrossRefPubMed
4.
go back to reference Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R: Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006, 47: 846-853. 10.1161/01.HYP.0000215363.69793.bb.CrossRefPubMed Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R: Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006, 47: 846-853. 10.1161/01.HYP.0000215363.69793.bb.CrossRefPubMed
5.
go back to reference Agena F, Dos Santos Prado E, Soarez Souza P, Da Silva GV, Lemos FB, Mion D, Nahas WC, David-Neto E: Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP. Nephrol Dial Transplant. 2011, 26: 3745-3749. 10.1093/ndt/gfr143.CrossRefPubMed Agena F, Dos Santos Prado E, Soarez Souza P, Da Silva GV, Lemos FB, Mion D, Nahas WC, David-Neto E: Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP. Nephrol Dial Transplant. 2011, 26: 3745-3749. 10.1093/ndt/gfr143.CrossRefPubMed
6.
go back to reference Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G: Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005, 111: 1777-1783. 10.1161/01.CIR.0000160923.04524.5B.CrossRefPubMed Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G: Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005, 111: 1777-1783. 10.1161/01.CIR.0000160923.04524.5B.CrossRefPubMed
7.
go back to reference Stergiou GS, Bliziotis IA: Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens. 2011, 24: 123-134. 10.1038/ajh.2010.194.CrossRefPubMed Stergiou GS, Bliziotis IA: Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens. 2011, 24: 123-134. 10.1038/ajh.2010.194.CrossRefPubMed
8.
go back to reference Burnier M, Bochud M, Schmieder R: Dietary sodium intake and hypertension. European Society of Hypertension Scientific Newsletter. 2009, 10: n°40 Burnier M, Bochud M, Schmieder R: Dietary sodium intake and hypertension. European Society of Hypertension Scientific Newsletter. 2009, 10: n°40
9.
go back to reference He F, Burnier M, MacGregor: Nutrition in cardiovascular disease: salt in hypertension and heart failure. Eur Heart J. 2011, 32: 3073-3080. 10.1093/eurheartj/ehr194.CrossRefPubMed He F, Burnier M, MacGregor: Nutrition in cardiovascular disease: salt in hypertension and heart failure. Eur Heart J. 2011, 32: 3073-3080. 10.1093/eurheartj/ehr194.CrossRefPubMed
10.
go back to reference World Health Organization: Prevention of Cardiovascular Disease: Guidelines for assessment and management of cardiovascular risk. 2007, World Health Organization, Geneva World Health Organization: Prevention of Cardiovascular Disease: Guidelines for assessment and management of cardiovascular risk. 2007, World Health Organization, Geneva
11.
go back to reference Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997, 277 (20): 1624-1632. 10.1001/jama.1997.03540440058033.CrossRefPubMed Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997, 277 (20): 1624-1632. 10.1001/jama.1997.03540440058033.CrossRefPubMed
12.
go back to reference Frisoli T, Schmieder R, Grodzicki T, Messerli F: Beyond salt :lifestyle modifications and blood pressure. Eur Heart J. 2011, 32: 3081-3087. 10.1093/eurheartj/ehr379.CrossRefPubMed Frisoli T, Schmieder R, Grodzicki T, Messerli F: Beyond salt :lifestyle modifications and blood pressure. Eur Heart J. 2011, 32: 3081-3087. 10.1093/eurheartj/ehr379.CrossRefPubMed
13.
go back to reference Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering TG, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G: ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension Practice Guidelines for home blood pressure monitoring. J Hum Hypertens. 2010, 24: 779-785. 10.1038/jhh.2010.54.CrossRefPubMed Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering TG, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G: ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension Practice Guidelines for home blood pressure monitoring. J Hum Hypertens. 2010, 24: 779-785. 10.1038/jhh.2010.54.CrossRefPubMed
14.
go back to reference NUBEL-Table belge de composition des aliments, (Bruxelles, juin 2009, 5e edition) and with the NUBEL database. www.nubel.com) NUBEL-Table belge de composition des aliments, (Bruxelles, juin 2009, 5e edition) and with the NUBEL database. www.nubel.com)
15.
go back to reference Institut Paul Lambin: Table de composition des aliments. 2004, 1200 Bruxelles Institut Paul Lambin: Table de composition des aliments. 2004, 1200 Bruxelles
16.
go back to reference Souci S, Fachmann W, Krout H: La composition des aliments, tableaux des valeurs nutritives. 1994, Medpharm, Stuggart, 5e Souci S, Fachmann W, Krout H: La composition des aliments, tableaux des valeurs nutritives. 1994, Medpharm, Stuggart, 5e
17.
go back to reference World Health Organization: Diet, nutrition and the prevention of chronic disease. Report of a Joint WHO/FAO Expert Consultation. 2003, WHO, Geneva, technical report n° 916 World Health Organization: Diet, nutrition and the prevention of chronic disease. Report of a Joint WHO/FAO Expert Consultation. 2003, WHO, Geneva, technical report n° 916
18.
go back to reference Opelz G, Döhler B: Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005, 5: 2725-2731. 10.1111/j.1600-6143.2005.01093.x.CrossRefPubMed Opelz G, Döhler B: Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005, 5: 2725-2731. 10.1111/j.1600-6143.2005.01093.x.CrossRefPubMed
19.
go back to reference Appel L, Moore T, Obarzanek E, Vollmer W, Svetkey L, Sacks F, Bray G, Vogt T, Cutler J, Windhauser M, Lin P, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997, 336: 1117-1124. 10.1056/NEJM199704173361601.CrossRefPubMed Appel L, Moore T, Obarzanek E, Vollmer W, Svetkey L, Sacks F, Bray G, Vogt T, Cutler J, Windhauser M, Lin P, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997, 336: 1117-1124. 10.1056/NEJM199704173361601.CrossRefPubMed
20.
go back to reference He F, MacGregor G: Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002, 16: 761-770. 10.1038/sj.jhh.1001459.CrossRefPubMed He F, MacGregor G: Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002, 16: 761-770. 10.1038/sj.jhh.1001459.CrossRefPubMed
21.
go back to reference Agena F, Prado Edos S, Souza PS, da Silva GV, Lemos FB, Mion D, Nahas WC, David-Neto E: Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP. Nephrol Dial Transplant. 2011, 26 (11): 3745-3749. 10.1093/ndt/gfr143.CrossRefPubMed Agena F, Prado Edos S, Souza PS, da Silva GV, Lemos FB, Mion D, Nahas WC, David-Neto E: Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP. Nephrol Dial Transplant. 2011, 26 (11): 3745-3749. 10.1093/ndt/gfr143.CrossRefPubMed
22.
go back to reference Covic A, Segall L, Goldsmith D: Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients?. Transplantation. 2003, 76 (11): 1640-1642. 10.1097/01.TP.0000091288.19441.E2.CrossRefPubMed Covic A, Segall L, Goldsmith D: Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients?. Transplantation. 2003, 76 (11): 1640-1642. 10.1097/01.TP.0000091288.19441.E2.CrossRefPubMed
23.
go back to reference Prasad G, Nash M, Zaltzman J: A prospective study of the physician effect on blood pressure in renal-transplant recipients. Nephrol Dial Transplant. 2003, 18: 996-1000. 10.1093/ndt/gfg038.CrossRefPubMed Prasad G, Nash M, Zaltzman J: A prospective study of the physician effect on blood pressure in renal-transplant recipients. Nephrol Dial Transplant. 2003, 18: 996-1000. 10.1093/ndt/gfg038.CrossRefPubMed
24.
go back to reference Curtis J, Luke R, Jones P, Dietheim A: Hypertension in cyclosporine-treated renal transplant recipients is sodium-dependent. Am J Med. 1988, 85: 134-138. 10.1016/S0002-9343(88)80331-0.CrossRefPubMed Curtis J, Luke R, Jones P, Dietheim A: Hypertension in cyclosporine-treated renal transplant recipients is sodium-dependent. Am J Med. 1988, 85: 134-138. 10.1016/S0002-9343(88)80331-0.CrossRefPubMed
25.
go back to reference Veenstra D, Best J, Hornberger J, Sullivan SD, Hricik DE: Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis. 1999, 33: 829-839. 10.1016/S0272-6386(99)70414-2.CrossRefPubMed Veenstra D, Best J, Hornberger J, Sullivan SD, Hricik DE: Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis. 1999, 33: 829-839. 10.1016/S0272-6386(99)70414-2.CrossRefPubMed
26.
go back to reference Brown I, Tzoulaki I, Elliott P: Salt intakes around the world: implications for public health. Int J Epidemiol. 2009, 38: 791-813. 10.1093/ije/dyp139.CrossRefPubMed Brown I, Tzoulaki I, Elliott P: Salt intakes around the world: implications for public health. Int J Epidemiol. 2009, 38: 791-813. 10.1093/ije/dyp139.CrossRefPubMed
27.
go back to reference Tasevska N, Runswick S, Bingham S: Urinary potassium is as reliable as urinary nitrogen for use as a recovery biomarker in dietary studies of free living individuals. J Nutr. 2006, 136: 1334-1340.PubMed Tasevska N, Runswick S, Bingham S: Urinary potassium is as reliable as urinary nitrogen for use as a recovery biomarker in dietary studies of free living individuals. J Nutr. 2006, 136: 1334-1340.PubMed
29.
go back to reference Chadban S, Chan M, Fry K, Patwardhan A, Ryan C, Trevillian P, Westgarth F: CARI. The CARI guidelines Nutritional management of hypertension in adult kidney transplant recipients. Nephrology. 2010, 15: S56-S61.CrossRefPubMed Chadban S, Chan M, Fry K, Patwardhan A, Ryan C, Trevillian P, Westgarth F: CARI. The CARI guidelines Nutritional management of hypertension in adult kidney transplant recipients. Nephrology. 2010, 15: S56-S61.CrossRefPubMed
30.
go back to reference He F, MacGregor G: A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009, 23: 363-384. 10.1038/jhh.2008.144.CrossRefPubMed He F, MacGregor G: A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009, 23: 363-384. 10.1038/jhh.2008.144.CrossRefPubMed
31.
go back to reference Stolar-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff, et al: fatal and nonfatal outcomes, incidence of hypertension and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011, 305 (17): 1777-1785. 10.1001/jama.2011.574.CrossRef Stolar-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff, et al: fatal and nonfatal outcomes, incidence of hypertension and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011, 305 (17): 1777-1785. 10.1001/jama.2011.574.CrossRef
32.
33.
go back to reference Mimran A, du Cailar G: Dietary sodium: the dark horse amongst cardiovascular and renal risk factors. Nephrol Dial Transplant. 2008, 23: 2138-2141. 10.1093/ndt/gfn160.CrossRefPubMed Mimran A, du Cailar G: Dietary sodium: the dark horse amongst cardiovascular and renal risk factors. Nephrol Dial Transplant. 2008, 23: 2138-2141. 10.1093/ndt/gfn160.CrossRefPubMed
34.
go back to reference Chioléro A, Würzner G, Burnier M: Renal determinants of the salt-sensitivity of blood pressure. Nephrol Dial Transplant. 2001, 16: 452-458. 10.1093/ndt/16.3.452.CrossRefPubMed Chioléro A, Würzner G, Burnier M: Renal determinants of the salt-sensitivity of blood pressure. Nephrol Dial Transplant. 2001, 16: 452-458. 10.1093/ndt/16.3.452.CrossRefPubMed
35.
go back to reference Geleijnse JM, Kok FJ, Grobbee DE: Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens. 2003, 17: 471-480. 10.1038/sj.jhh.1001575.CrossRefPubMed Geleijnse JM, Kok FJ, Grobbee DE: Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens. 2003, 17: 471-480. 10.1038/sj.jhh.1001575.CrossRefPubMed
36.
go back to reference Haddy F, Vanhoutte P, Feletou M: Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006, 290: R546-R552.CrossRefPubMed Haddy F, Vanhoutte P, Feletou M: Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006, 290: R546-R552.CrossRefPubMed
37.
go back to reference Adrogué H, Madias N: Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007, 356: 1966-1978. 10.1056/NEJMra064486.CrossRefPubMed Adrogué H, Madias N: Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007, 356: 1966-1978. 10.1056/NEJMra064486.CrossRefPubMed
38.
go back to reference Moeller T, Buhl M, Schorr U, Distler A, Sharma AM: Salt intake and hypertension in renal transplant patients. Clin Nephrol. 2000, 53 (3): 159-163.PubMed Moeller T, Buhl M, Schorr U, Distler A, Sharma AM: Salt intake and hypertension in renal transplant patients. Clin Nephrol. 2000, 53 (3): 159-163.PubMed
39.
go back to reference Prasad G, Huang M, Nash M, Zaltzman: Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression. Transpl Proc. 2005, 37: 1896-1897. 10.1016/j.transproceed.2005.04.002.CrossRef Prasad G, Huang M, Nash M, Zaltzman: Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression. Transpl Proc. 2005, 37: 1896-1897. 10.1016/j.transproceed.2005.04.002.CrossRef
40.
go back to reference Prasad G, Huang M, Nash M, Zaltzman: The role of dietary cations in the blood pressure of renal transplant recipients. Clin Transplant. 2006, 20 (1): 37-42. 10.1111/j.1399-0012.2005.00437.x.CrossRef Prasad G, Huang M, Nash M, Zaltzman: The role of dietary cations in the blood pressure of renal transplant recipients. Clin Transplant. 2006, 20 (1): 37-42. 10.1111/j.1399-0012.2005.00437.x.CrossRef
41.
go back to reference Keven K, Yalçin S, Canbakan S, Kutlay S, Sengül S, Erturk S, Erbay B: The impact of daily sodium intake on posttransplant hypertension in kidney allograft recipients. Transplant Proc. 2006, 38: 1323-1326. 10.1016/j.transproceed.2006.02.103.CrossRefPubMed Keven K, Yalçin S, Canbakan S, Kutlay S, Sengül S, Erturk S, Erbay B: The impact of daily sodium intake on posttransplant hypertension in kidney allograft recipients. Transplant Proc. 2006, 38: 1323-1326. 10.1016/j.transproceed.2006.02.103.CrossRefPubMed
42.
go back to reference Van den Berg E, Geleijnse J, Brink E, Van Baak M, Homan Van Der Heide J, Gans R, Navis G, Bakker S: Sodium intake and blood pressure in renal transplant recipients. Nephrol Dial Transplant. 2012, 27 (8): 3352-3359. 10.1093/ndt/gfs069.CrossRefPubMed Van den Berg E, Geleijnse J, Brink E, Van Baak M, Homan Van Der Heide J, Gans R, Navis G, Bakker S: Sodium intake and blood pressure in renal transplant recipients. Nephrol Dial Transplant. 2012, 27 (8): 3352-3359. 10.1093/ndt/gfs069.CrossRefPubMed
43.
go back to reference Vegter S, Perna A, Postma M, Navis G, Remuzzi G, Ruggenenti P: Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012, 23: 165-173. 10.1681/ASN.2011040430.CrossRefPubMed Vegter S, Perna A, Postma M, Navis G, Remuzzi G, Ruggenenti P: Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012, 23: 165-173. 10.1681/ASN.2011040430.CrossRefPubMed
44.
go back to reference Cook N, Obarzanek E, Cutler J, Buring J, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK: Trials of Hypertension Prevention Collaborative Research Group. Joint effects of sodium and potassium intake on subsequent cardiovascular disease. Arch Intern Med. 2009, 169 (1): 32-40. 10.1001/archinternmed.2008.523.CrossRefPubMedPubMedCentral Cook N, Obarzanek E, Cutler J, Buring J, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK: Trials of Hypertension Prevention Collaborative Research Group. Joint effects of sodium and potassium intake on subsequent cardiovascular disease. Arch Intern Med. 2009, 169 (1): 32-40. 10.1001/archinternmed.2008.523.CrossRefPubMedPubMedCentral
45.
go back to reference Leiba A, Vald A, Peleg E, Shamiss A, Grossmann E: Does dietary recall adequately assess sodium, potassium, and calcium intake in hypertensive patients?. Nutrition. 2005, 21 (4): 462-466. 10.1016/j.nut.2004.08.021.CrossRefPubMed Leiba A, Vald A, Peleg E, Shamiss A, Grossmann E: Does dietary recall adequately assess sodium, potassium, and calcium intake in hypertensive patients?. Nutrition. 2005, 21 (4): 462-466. 10.1016/j.nut.2004.08.021.CrossRefPubMed
Metadata
Title
Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study
Authors
Annie Saint-Remy
Mélanie Somja
Karen Gellner
Laurent Weekers
Catherine Bonvoisin
Jean-Marie Krzesinski
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-121

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine